Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Noble Corporation plc (NE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Noble Corporation plc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Noble Corporation plc trades at $42.5 (market cap $6.73B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Noble Corporation plc pays a 4.74% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Noble Corporation plc for 26 Days on average.
| HALO | NE | |
|---|---|---|
Market Cap | $12.58B | $6.73B |
Volume | 2,179,278 | 1,027,635 |
Sector | Health | Energy |
52-Week High | $115.22 | $54.37 |
52-Week Low | $61.63 | $26.70 |
Typical Hold Time | 1 Days | 26 Days |
Enterprise Value | $14.49B | $8.16B |
Dividend Yield | — | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Noble Corporation (NE) trades at $42.36, up 3.39% on the day. The stock shows mixed signals with a bearish technical trend but positive analyst sentiment, evidenced by a consensus price target of $52.00. Recent earnings have been volatile, with a beat in Q1 2026 but misses in Q4 2025 and Q2 2026. Financially, the company reported 2025 revenue of $3.29 billion and net income of $216.72 million, though 2026 projections indicate a decline in both revenue and profitability. A key recent development is the securing of a long-term drilling contract in Ghana, extending utilization into 2027.
The outlook for NE is cautiously optimistic, supported by new contracts and a positive analyst consensus, but tempered by earnings volatility and a bearish technical setup. Investment opportunities lie in the potential upside to the price target and stable cash flows, while risks include inconsistent earnings performance and ongoing legal investigations noted in recent news. Investors should weigh contract wins against fundamental softness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →
